The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Amgen's ($AMGN) tarlatamab (Imdyllytra) to treat small cell lung cancer.
https://www.tipranks.com/news/the-uk-approves-amgens-amgn-tarlatamab-for-small-cell-lung-cancer
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Amgen's ($AMGN) tarlatamab (Imdyllytra) to treat small cell lung cancer.
https://www.tipranks.com/news/the-uk-approves-amgens-amgn-tarlatamab-for-small-cell-lung-cancer
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.